FH and hereditary clear cell renal cell carcinoma: Twenty-five (40%) participating uropathologists have encountered low-grade oncocytic renal neoplasms that are deficient for fumarate hydratase (FH, mimicking SDH-deficient renal cell carcinoma), typically within consultation practice, whereas 35 (56%) have not (Question #27).